Investor Presentaiton

Revenue: Business Units (incl. Forex Impact) Daiichi-Sankyo (Bn JPY) 0000 Japan Business FY2021 Q1 FY2022 Q1 YOY Results Results 129.1 109.0 -20.1 Daiichi Sankyo Healthcare 15.4 15.3 -0.1 Oncolgy Business 14.5 27.5 +13.1 Enhertu 10.8 26.7 +15.9 Turalio 0.6 0.8 +0.2 American Regent 39.1 47.0 +7.9 Injectafer 14.9 14.1 -0.8 Venofer 7.9 12.4 +4.5 GE injectables 13.8 17.6 +3.8 EU Speciality Business 32.7 37.1 +4.4 Lixiana 23.4 28.6 +5.2 Nilemdo/Nustendi 0.7 1.3 +0.6 Olmesartan 5.6 5.4 -0.2 ASCA (Asia, South and Central America) Business 26.5 31.9 +5.4 Currency Rate USD/JPY 109.49 129.57 +20.08 EUR/JPY 131.95 138.10 +6.15 8

View entire presentation